Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Tests for primary aldosteronism and mineralocorticoid receptor antagonist use in American veterans: a retrospective cohort study. Ann Intern Med. 2021;174(3):289–97.
Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P. Prevalence of apparent treatment-resistant hypertension in the United States. Hypertension. 2019;73(2):424–31.
Wu C, Wang Y, Zhang W, Li X, Wang L, Hui R. Prevalence and characteristics of apparent treatment-resistant hypertension among the elderly in China: a cross-sectional study. Clin Exp Hypertens. 2019;41(8):753–8.
Consortium G. The GTEx Consortium Atlas of Genetic Regulatory Effects in Human Tissues. Science. 2020;369(6509):1318–30.
Li H, Pei F, Shao L, Chen J, Sun K, Zhang X, et al. Prevalence and risk factors of abnormal left ventricular geometric patterns in untreated hypertensive patients. BMC Cardiovascular Disorders. 2014;14(1):1–7.
Yan Y, Wang J, Yu L, Cui B, Wang H, Xiao X, et al. ANKRD36 is implicated in hypertension by modifying the expression of ENaC genes. Circ Res. 2021;129(11):1067–81.
Cui B, Xiao X, Wang J, Wang H, Wu C, Yan Y, et al. Low levels of thyroid hormone receptor beta (THRB) promoter methylation in peripheral blood leukocytes induced by systematic inflammation are implicated in low thyroid hormone function in metabolic syndrome. Hypertension. 2021;78(4):1005–15.
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second Generation PLINK: Meeting the Challenge of Larger and Richer Datasets. Gigascience. 2015;4(1):s13742-13015-10047-13748.
Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. National protocol 2010;5(9):1564–73.
Lemieux Perreault LP, Legault MA, Asselin G, Dubé MP. Genipe: an automated genome-wide imputation pipeline with automatic reporting and statistical tools. Bioinformatics. 2016;32(23):3661–3.
Delaneau O, Marchini J. Integration of sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Natural communication. 2014;5(1):1–9.
Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program to annotate and predict the effects of single nucleotide polymorphisms, SnpEff:SNP in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 2012;6(2):80–92.
Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: Regional visualization of genome-wide association analysis results. Bioinformatics. 2010;26(18):2336–7.
Boughton AP, Welch RP, Flickinger M, VandeHaar P, Taliun D, Abecasis GR, et al. LocusZoom. js: interactive and embeddable visualization of the results of genetic association studies. Bioinformatics. 2021;37(18):3017–8.
Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J, Patterson N, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291–5.
Zheng J, Erzurumluoglu AM, Elsworth BL, Kemp JP, Howe L, Haycock PC, et al. LD Hub: A centralized database and web interface for performing LD score regression that maximizes the potential of summary-level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics. 2017;33(2):272–9.
Wang L, Lv Q, He Y, Gu R, Zhou B, Chen J, et al. Integrated qPCR and staining methods for the detection and quantification of Enterocytozoon hepatopenaei in Shrimp Litopenaeus vannamei. Microorganisms. 2020;8(9):1366.
Padmanabhan S, Caulfield M, Dominiczak AF. Genetic and molecular aspects of hypertension. Circ Res. 2015;116(6):937–59.
Padmanabhan S, Dominiczak AF. Genomics of hypertension: the path to precision medicine. Nat Rev Cardiol. 2021;18(4):235–50.
ICfBPG-WA studies. Genetic variants in new pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103.
Tegegne BS, Man T, van Roon AM, Asefa NG, Riese H, Nolte I, et al. The heritability and genetic correlation of heart rate and blood pressure variability in >29,000 families: the Lifelines Cohort Study. Hypertension. 2020;76(4):1256–62.
Irvin MR, Sitlani CM, Floyd JS, Psaty BM, Bis JC, Wiggins KL, et al. Genome-wide association study of apparent treatment-resistant hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetic Working Group. Am J Hypertens. 2019;32(12):1146–53.
Jhuo SJ, Tsai WC, Lee HC, Lin TH, Lee KT, Lai W-TJG. Association between adiponectin T94G polymorphism and resistant hypertension in young-onset Taiwanese patients. Embarrassed. 2019;689:161–5.
Gong Y, McDonough CW, Beitelshees AL, El Rouby N, Hiltunen TP, O’Connell JR, et al. PTPRD gene associated with blood pressure response to atenolol and resistant hypertension. J Hypertens. 2015;33(11):2278.
Dumitrescu L, Ritchie MD, Denny JC, El Rouby NM, McDonough CW, Bradford Y, et al. Genome-wide study of resistant hypertension identified from electronic health records. PloS one. 2017;12(2):e0171745.
El Rouby N, McDonough CW, Gong Y, McClure LA, Mitchell BD, Horenstein RB, et al. Genome-wide association analysis of common genetic variants of resistant hypertension. Pharmacogenomics J. 2019;19(3):295–304.
Takahashi Y, Yamazaki K, Kamatani Y, Kubo M, Matsuda K, Asai S. Genome-wide association study identifies novel candidate locus at DLGAP1 gene with population-resistant hypertension susceptibility Japanese. Sci Rep. 2021;11(1):1–11.
Fontana V, McDonough CW, Gong Y, El Rouby NM, Sá ACC, Taylor KD, et al. Large-scale gene-focused analysis identifies polymorphisms of resistant hypertension. J Am Heart Assoc. 2014;3(6):e001398.
Kerimov N, Hayhurst JD, Peikova K, Manning JR, Walter P, Kolberg L, et al. eQTL Catalog: A compendium of uniformly processed human gene expressions and splicing QTLs. Nat. Genetics 2021; 53(9):1290-9
D’Antonio M, Nguyen JP, Arthur TD, Matsui H, D’Antonio-Chronowska A, Frazer KA, et al. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues. Cell Rep. 2021;37(7):110020.
Zhao L, Wang S, Xu M, He Y, Zhang X, Xiong Y, et al. Vpr counteracts restriction of LAPTM5 to promote HIV-1 infection in macrophages. Common Nat. 2021;12(1):1–14.
Li T, Wang W, Gan W, Lv S, Zeng Z, Hou Y, et al. A comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy. Aging (Albany NY). 2022;14(3):1508.
Xu X, Grijalva A, Skowronski A, van Eijk M, Serlie MJ, Ferrante AW Jr. Obesity activates a lysosomal-dependent lipid metabolism program in adipose tissue macrophages independent of classical activation. Metab cell. 2013;18(6):816–30.
Hochberg I, Harvey I, Tran QT, Stephenson EJ, Barkan AL, Saltiel AR, et al. Changes in gene expression in subcutaneous adipose tissue due to Cushing’s disease. J Mol Endocrinol. 2015;55(2):81.
Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, et al. FXR induces the enzyme UGT2B4 in hepatocytes: a potential negative feedback mechanism of FXR activity. Gastroenterology. 2003;124(7):1926–40.
Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, et al. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res. 1999;59(19):4990–6.
Chang BC-C, Hwang LC, Huang WH. Positive association of metabolic syndrome with a single nucleotide polymorphism of Syndecan-3 (rs2282440) in the Taiwanese population. Int J Endocrinol. 2018;2018.
Reizes O, Lincecum J, Wang Z, Goldberger O, Huang L, Kaksonen M, et al. Transgenic expression of syndecan-1 reveals physiological control of eating behavior by syndecan-3. Cell. 2001;106(1):105–16.
Strader AD, Reizes O, Woods SC, Benoit SC, Seeley RJ. Mice lacking the syndecan-3 gene are resistant to diet-induced obesity. J Clin Investig. 2004;114(9):1354–60.
Dodoo SN, Benjamin IJ. Genomic approaches to hypertension. Cardiol Clin. 2017;35(2):185–96.
Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Eight blood pressure loci identified by a genome-wide association study of 34,433 people of European ancestry. Nat Genet. 2009;41(6):666.
Martin-Lorenzo M, Martinez PJ, Baldan-Martin M, Ruiz-Hurtado G, Prado JC, Segura J, et al. Citric acid metabolism in resistant hypertension: underlying mechanisms and metabolic prediction of treatment response. Hypertension. 2017;70(5):1049–56.
Cao N, Tang H, Tian M, Gong X, Xu Z, Zhou B, et al. GRK4 genetic variants influence blood pressure circadian rhythm and response to candesartan in hypertensive patients. Clin Exp Hypertens. 2021;43(7):597–603.
Takeuchi F, Isono M, Katsuya T, Yamamoto K, Yokota M, Sugiyama T, et al. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Traffic. 2010;121(21):2302–9.
Tapia-Castillo A, Carvajal CA, López-Cortés X, Vecchiola A, Fardella CE. New metabolomic profile of subjects with apparent non-classical mineralocorticoid excess. Scientific Rep. 2021;11(1):1–12.
Kyoung J, Atluri RR, Yang TJH. Antihypertensive drug resistance: is the gut microbiota the missing link? Hypertension. 2022;79(10):2138-47.
Givens RC, Lin YS, Dowling AL, Thummel KE, Lamba JK, Schuetz EG, et al. CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. J Appl Physiol. 2003;95(3):1297–300.
Ho H, Pinto A, Hall SD, Flockhart DA, Li L, Skaar TC, et al. Association between CYP3A5 genotype and blood pressure. Hypertension. 2005;45(2):294–8.
Makris A, Seferou M, Papadopoulos DP. Assessment of resistant hypertension and therapeutic approach. Int J Hypertens. 2010;2011.
#Genomewide #association #study #identifies #association #SDC3 #apparent #treatmentresistant #hypertension #BMC #Medicine